Valuation Services and COVID-19
April 8, 2020
The COVID-19 pandemic and the resulting slow down or temporary cessation of many businesses has triggered a massive sell-off in equities, as investors have cut projections and raised equity risk profiles for publicly traded investments in this time of uncertainty. The sudden decline in equity values provides both challenges and opportunities for business owners and... Read More
Economic Stimulus Legislation and the Valuation of Privately Held Businesses
April 8, 2020
In response to the substantial economic disruption caused by the COVID-19 pandemic and the associated business shutdowns, the U.S. enacted a series of stimulus measures in late March, including the Coronavirus Aid, Relief, and Economic Security (CARES) Act, the largest stimulus bill in U.S. history. Among other measures, the CARES Act: Provides funding to various... Read More
Gleason CLE Event – Opioid Litigation: Extraordinary Justice in Extraordinary Times
October 22, 2019
November 12, 2019 Fairmont Hotel | 501 Market Street, Pittsburgh, PA 15222 5:00 p.m. Registration | 5:30 p.m. Presentation & Discussion | 6:30 p.m. Networking Reception x Opioid Litigation: Extraordinary Justice in Extraordinary Times "Ordinarily, the resolution of a social epidemic should be the responsibility of our other two branches of government, but these are... Read More
Mid-Year Market Update: July 2018
July 18, 2018
Market Review and Outlook The M&A market had a huge first half of 2018, with total announced deal value reaching a record of $2.5 trillion - a 61% increase over the first half of 2017. While overall value is up this year, deal volume slowed by nearly 4% from the same period in 2017. This drop continues... Read More